Preventative ibandronate treatment has the most beneficial effect on the microstructure of bone in experimental tumor osteolysis

Journal of Bone and Mineral Metabolism

Volumn 25, Issue 2, 2007, Pages 86-92

  Kurth, Andreas A ^a   Kim, Soo Zin ^a   Shea, Marie ^b   Bauss, Frieder ^c   Hayes, Wilson C ^d   Müller, Ralph ^e  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c ROCHE DIAGNOSTICS GMBH   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Bisphosphonate; Computer tomography; Preclinical; Skeletal integrity

Indexed keywords

IBANDRONIC ACID; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE DISEASE; BONE MASS; BONE MINERAL; BONE STRENGTH; BONE STRUCTURE; BONE TUMOR; CANCER TRANSPLANTATION; CARCINOMA CELL; CONTROLLED STUDY; FEMALE; FEMUR; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; TRABECULAR BONE; WALKER CARCINOMA;

ANIMALS; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; CARCINOMA 256, WALKER; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; FEMALE; FEMUR; IMAGE PROCESSING, COMPUTER-ASSISTED; RATS;

EID: 33847278891     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-006-0732-x     Document Type: Article

References (44)

1. H Fleisch 2000 Bisphosphonates in Bone Disease Academic Press San Diego
2. IJ Diel EF Solomayer G Bastert 2000 Bisphosphonates and the prevention of metastasis: first evidences from preclinical and clinical studies Cancer (Phila) 88 3080 3088
3. A Guaitani N Polentarutti S Filippeschi L Marmonti F Corti C Italia G Coccioli MG Donelli A Mantovani S Garattini 1984 Effects of disodium etidronate in murine tumor models Eur J Cancer Clin Oncol 20 685 693
4. DG Hall G Stoica 1994 Effect of the bisphosphonate risedronate on bone metastases in a rat mammary adenocarcinoma model system J Bone Miner Res 9 221 230
5. A Jung J Bornand B Mermillod C Edouard PJ Meunier 1984 Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat Cancer Res 44 3007 3011
6. PJ Kostenuik FW Orr K Suyama G Singh 1993 Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats Cancer Res 53 5452 5457
7. B Krempien IJ Diel B Jöckle-Kretz R Buchele L Andre 1984 The Walker carcinosarcoma 256 as an experimental model of bone metastasis. Influence of skeletal metabolism on the development of bone metastases Verh Dtsch Ges Pathol 68 211 216
8. B Krempien C Manegold 1993 Prophylactic treatment of skeletal metastases, tumor-induced osteolysis, and hypercalcemia in rats with the bisphosphonate Cl2MBP Cancer (Phila) 72 91 98
9. B Krempien F Wingen T Eichmann M Muller D Schmahl 1988 Protective effects of a prophylactic treatment with the bisphosphonate 3-amino-1-hydroxypropane-1, 1-bisphosphonic acid on the development of tumor osteopathies in the rat: experimental studies with the Walker carcinosarcoma 256 Oncology 45 41 46
10. IJ Diel 2000 Antitumour effects of bisphosphonates: first evidence and possible mechanisms Drugs 59 391 399
11. AA Kurth SZ Kim I Sedlmeyer F Bauss M Shea 2002 Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the rat Bone (NY) 30 300 306
12. R Muller T Hildebrand P Ruegsegger 1994 Non-invasive bone biopsy: a new method to analyse and display the 3-dimensional structure of trabecular bone Phys Med Biol 39 145 164
13. AA Kurth R Muller 2001 The effect of an osteolytic tumor on the 3-dimensional trabecular bone morphology in an animal model Skeletal Radiol 30 94 98
14. AHA Kurth S-Z Kim I Sedlmeyer L Hovy F Bauss 2000 Treatment with ibandronate preserves bone in experimental tumour-induced bone loss J Bone Joint Surg 82B 126 130
15. AA Kurth CO Wang WC Hayes M Shea 2001 The evaluation of a rat model for the analysis of densitometric and biomechanical properties of tumor-induced osteolysis J Orthop Res 19 200 205
16. R Müller M Hannan SY Smith F Bauss 2004 Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey J Bone Miner Res 19 1787 1796
17. A Nazarian D von Stechow JY Rho M Grynpas D Zurakowski R Müller BD Snyder 2005 Structure dominates tissue properties in metastatic cancer Cancer Treat Rev 31 suppl 1 S53 S54 abstract 103
18. S Lalla LA Hothorn N Haag R Bader F Bauss 1998 Lifelong administration of high doses of ibandronate increases bone mass and maintains bone quality of lumbar vertebrae in rats Osteoporos Int 8 97 103
19. F Bauss RG Russell 2004 Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing Osteoporos Int 15 423 433
20. A Pataki K Muller JR Green YF Ma QN Li WS Jee 1997 Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: a comparative histomorphometric study on the cancellous bone formed before, during, and after treatment Anat Rec 249 458 468
21. O Peyruchaud B Winding I Pécheur CM Serre P Delmas P Clezardin 2001 Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application of to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions J Bone Miner Res 16 2027 2034
22. A Laib JL Kumer S Majumdar NE Lane 2001 The temporal changes of trabecular architecture in ovariectomized rats assessed by microCT Osteoporosis Int 12 936 941
23. NE Lane JL Kumer S Majumdar M Khan J Lotz RE Stevens R Klein KV Phelps 2002 The effects of synthetic conjugated estrogens A (cenestin) on trabecular bone structure and strength in the ovariectomized rat model Osteoporosis Int 13 816 823
24. P Rüegsegger B Koller R Müller 1996 A microtomograpic system for nondestructive evaluation of bone architecture Calcif Tissue Int 58 24 29
25. T Hildebrand A Laib R Müller J Dequeker P Ruegsegger 1999 Direct 3-D morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus J Bone Miner Res 14 1167 1174
26. B Borah TE Dufresne PA Chmielewski GJ Gross MC Prenger RJ Phipps 2002 Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by 3-dimensional microcomputed tomography J Bone Miner Res 17 1139 1147
27. Y Jiang JJ Zhao BH Mitlak O Wang HK Genant EF Eriksen 2003 Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure J Bone Miner Res 18 1932 1941
28. B Borah TE Dufresne PA Chmielewski TD Johnson A Chines MD Manhart 2004 Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography Bone (NY) 34 736 746
29. R Nemoto K Uchida M Tsutsumi K Koiso S Satou T Satou 1987 A model of localized osteolysis induced by the MBT-2 tumor mice and its responsiveness to etidronate disodium J Cancer Res Clin Oncol 113 539 543
30. F Wingen T Eichmann C Manegold B Krempien 1986 Effects of new bisphosphonic acids on tumor-induced bone destruction in the rat J Cancer Res Clin Oncol 111 35 41
31. T Yoneda A Sasaki C Dunstan PJ Williams F Bauss YA De Clerck GR Mundy 1997 Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2 J Clin Invest 99 2509 2517
32. A Sasaki BF Boyce B Story KR Wright M Chapman R Boyce GR Mundy 1995 Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice Cancer Res 55 3551 3557
33. M Neudert C Fischer B Krempien F Bauss MJ Seibel 2003 Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterisation and in vivo effects of ibandronate on tumour growth Int J Cancer 107 468 477
34. DE Hughes KR Wright HL Uy A Sasaki T Yoneda GD Roodman GR Mundy BF Boyce 1995 Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo J Bone Miner Res 10 1478 1487
35. T Hiraga PJ Williams GR Mundy T Yoneda 2001 The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases Cancer Res 61 4418 4424
36. C Vitte H Fleisch HL Guenther 1996 Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption Eur J Cancer Clin Oncol 137 2324 2333
37. MJ Rogers KM Chilton FP Coxon J Lawry MO Smith S Suri RG Russell 1996 Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide independent mechanism J Bone Miner Res 11 1482 1491
38. KS Selander J Monkkonen EK Karhukorpi P Harkonen R Hannuniemi HK Vaananen 1996 Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages Mol Pharmacol 50 1127 1138
39. CM Shipman MJ Rogers JF Apperley RG Russell PI Croucher 1997 Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity Br J Haematol 98 665 672
40. G van der Pluijm H Vloedgraven E Van Beek L Van Der Wee-Pals C Lowik S Papapoulos 1996 Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro J Clin Invest 98 698 705
41. S Boissier S Magnetto L Frappart B Cuzin FH Ebetino PD Delmas P Clezardin 2003 Bisphosphonates inhibit prostate and breast cancer call adhesion to unmineralized and mineralized bone extracellular matrices Cancer Res 57 3890 3894
42. O Teronen P Heikkila YT Konttinen M Laitinen T Salo R Hanemaaijer A Teronen P Maisi T Sorsa 1999 MMP inhibition and down regulation by bisphosphonates Ann NY Acadv Sci 878 453 465
43. IJ Diel EF Solomayer SD Costa C Gollan R Goerna D Wallwiener M Kaufmann G Bastert 1998 Reduction in new metastases in breast cancer with adjuvant clodronate treatment N Engl J Med 339 357 363
44. T Powles S Paterson JA Kanis 2002 Randomized placebo-controlled trial of clodronate in patients with primary operable breast cancer J Clin Oncol 20 3219 3224